Citations

Citations to this article as recorded by  

• Beyond BMI: Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
  Ru‐Tao Lin, Ren‐Qiang Zeng, Xu‐Ting Shen, Qin‐Mei Sun, Xin Xin, Jia‐Mei Chen, Yi‐Yang Hu, Qin Feng
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt
  Mohamed M. Elhoseeny, Fatma Rageh, Samar M. Rezk, Amira A. A. Othman
  Scientific Reports.2025;[Epub]     CrossRef
• Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison
  Milena Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera Stanojlović, Dušan Mladenović
  International Journal of Molecular Sciences.2024; 25(13): 7405.     CrossRef
• The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology
  Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Dong Joon Kim, Ki-Tae Suk
  Food Chemistry.2024; 460: 140616.     CrossRef
• Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
  Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng
  Cureus.2024;[Epub]     CrossRef
• Non-alcoholic fatty liver disease in people with normal body weight
  S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko
  Experimental and Clinical Gastroenterology.2024; (10): 36.     CrossRef